618 related articles for article (PubMed ID: 27641687)
1. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges.
Yi L; Li J
Biochim Biophys Acta; 2016 Dec; 1866(2):197-207. PubMed ID: 27641687
[TBL] [Abstract][Full Text] [Related]
2. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
Wu HY; Cao CY
Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9: A Potent Gene-editing Tool for the Treatment of Cancer.
Mishra G; Srivastava K; Rais J; Dixit M; Kumari Singh V; Chandra Mishra L
Curr Mol Med; 2024; 24(2):191-204. PubMed ID: 36788695
[TBL] [Abstract][Full Text] [Related]
4. Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges.
Rafii S; Tashkandi E; Bukhari N; Al-Shamsi HO
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205694
[TBL] [Abstract][Full Text] [Related]
5. Applications and advances of CRISPR-Cas9 in cancer immunotherapy.
Xia AL; He QF; Wang JC; Zhu J; Sha YQ; Sun B; Lu XJ
J Med Genet; 2019 Jan; 56(1):4-9. PubMed ID: 29970486
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
7. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
Liu C; Zhang L; Liu H; Cheng K
J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 as a Tool in Cancer Therapy.
Zatloukalová P; Krejčíř R; Valík D; Vojtěšek B
Klin Onkol; 2019; 32(Supplementum 3):13-18. PubMed ID: 31627701
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9 therapies in experimental mouse models of cancer.
Estêvão D; Rios Costa N; da Costa RG; Medeiros R
Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-Mediated Genome Editing of Epigenetic Factors for Cancer Therapy.
Yao S; He Z; Chen C
Hum Gene Ther; 2015 Jul; 26(7):463-71. PubMed ID: 26075804
[TBL] [Abstract][Full Text] [Related]
12. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research.
Aquino-Jarquin G
Cancer Res; 2017 Dec; 77(24):6812-6817. PubMed ID: 29208606
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 and cancer targets: future possibilities and present challenges.
White MK; Khalili K
Oncotarget; 2016 Mar; 7(11):12305-17. PubMed ID: 26840090
[TBL] [Abstract][Full Text] [Related]
14. Application of CRISPR-mediated genome engineering in cancer research.
Sayin VI; Papagiannakopoulos T
Cancer Lett; 2017 Feb; 387():10-17. PubMed ID: 27000990
[TBL] [Abstract][Full Text] [Related]
15. Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.
Liu T; Shen JK; Li Z; Choy E; Hornicek FJ; Duan Z
Cancer Lett; 2016 Apr; 373(1):109-118. PubMed ID: 26806808
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
17. Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
Ren J; Zhao Y
Protein Cell; 2017 Sep; 8(9):634-643. PubMed ID: 28434148
[TBL] [Abstract][Full Text] [Related]
18. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
19. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9: a new and promising player in gene therapy.
Xiao-Jie L; Hui-Ying X; Zun-Ping K; Jin-Lian C; Li-Juan J
J Med Genet; 2015 May; 52(5):289-96. PubMed ID: 25713109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
